Vemurafenib Inhibits Enterovirus A71 Genome Replication and Virus Assembly.

ABSTRACT: Enterovirus A71 (EV-A71) infection is a major cause of hand, foot, and mouth disease (HFMD), which may be occasionally associated with severe neurological complications. There is currently a lack of treatment options for EV-A71 infection. The Raf-MEK-ERK signaling pathway, in addition to its critical importance in the regulation of cell growth, differentiation, and survival, has been shown to be essential for virus replication. In this study, we investigated the anti-EV-A71 activity of vemurafenib, a clinically approved B-Raf inhibitor used in the treatment of late-stage melanoma. Vemurafenib exhibits potent anti-EV-A71 effect in cytopathic effect inhibition and viral load reduction assays, with half maximal effective concentration (EC₅₀) at nanomolar concentrations. Mechanistic

SUBMITTER: Hu B 

PROVIDER: S-EPMC9500672 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature